絞り込み

18452

広告

Cost-effectiveness of grass pollen subcutaneous immunotherapy (SCIT) compared to sublingual immunotherapy (SLIT) and symptomatic treatment in Austria, Spain and Switzerland.

著者 Brüggenjürgen B , Reinhold T
J Med Econ.2017 Dec 22 ; ():1-18.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (18view , 0users)

Full Text Sources

Medical

While specific immunotherapy (SIT) has been proven to be cost effective for the treatment of allergic rhinitis compared to symptomatic treatment, there is a lack of European studies in which sublingual (SLIT) and subcutaneous (SCIT) immunotherapy were compared. The present analysis is focused on the cost-effectiveness of SCIT compared to SLIT and symptomatic treatment of grass pollen allergy in Austria, Spain and Switzerland. It will address specific properties of the underlying healthcare systems.
PMID: 29271271 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード